By Iain Gilbert
Date: Tuesday 01 Sep 2026
(Sharecast News) - LONDON PRE-OPEN
The FTSE 100 was expected to open 1.5 points lower ahead of the bell on Tuesday.
STOCKS TO WATCH
Drugmaker AstraZeneca has finalised its exclusive agreement with Dizal Pharmaceutical for worldwide rights to develop and commercialise Zegfrovy, an oral EGFR inhibitor already approved in...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news